Epilepsy Clinical Trial
— ETAPEOfficial title:
Attentional Impairment in People With Epilepsy
Epilepsy is one of the most common chronic neurological conditions.It leads to cognitive
impairment in 20-50% of patients with a structural form.
In comparison with seizures, these cognitive disorders are a major additional factor in
occupational, social and family disability. They are particularly frequent (50%) in temporal
epilepsies and preferably concern memory and language skills.
The cognitive consequences of epilepsy are therefore well described in the following areas:
episodic memory, language, executive functions.
Concerning attentional abilities, a recent review has highlighted the lack of work in this
specific field in order to properly measure the prevalence and nature of attentional
disorders in epileptic patients. Indeed, attentional abilities are often mentioned in
studies, but attention is a complex domain defined by four modalities: alertness, selective
attention, divided attention and sustained attention. No study systematically assesses all of
these modalities.
The objective of this study is to evaluate the prevalence and nature of attentional disorders
in epileptic patients compared to control subjects.
Status | Not yet recruiting |
Enrollment | 272 |
Est. completion date | August 2025 |
Est. primary completion date | May 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Patients: Inclusion Criteria: - Patient with epilepsy, according to Fisher et al. (2005). - Patient with written informed consent - affiliation to a social security regime is compulsory - Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data. - Patient 18 years of age and older Normal controls: Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data. - People 18 years of age and older - People with no neurological and/or psychiatric history Exclusion Criteria: for patients: with another progressive neurological condition for all People of full age who are subject to a legal protection measure or who are unable to express their consent People deprived of their liberty by a judicial or administrative decision People who regularly use psychoactive substances (cannabis, alcohol...) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Central Hospital, Nancy, France |
Brissart H, Forthoffer N, Maillard L. Attention disorders in adults with epilepsy. Determinants and therapeutic strategies. Rev Neurol (Paris). 2019 Mar;175(3):135-140. doi: 10.1016/j.neurol.2019.01.394. Epub 2019 Feb 28. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | digit span | immediate memory task | 5 minutes | |
Other | verbal fluency | executive task | 5 minutes | |
Other | incompatibility TAP subtest | executive task | 8 minutes | |
Other | flexibility TAP subtest | executive task | 8 minutes | |
Other | Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) | Depression scale score 0 to 24 | 3 minutes | |
Other | GENERALIZED ANXIETY DISORDER (GAD-7) | ANXIETY scale score : 0 to 21 | 3 minutes | |
Primary | d2-r | selective attention task | 10 minutes | |
Secondary | sustained attention TAP Subtest | Your task is to press the key as quickly as possible whenever two successive patterns have the same shape | 15 minutes | |
Secondary | alertness attention TAP Subtest | a cross appears on the screen. press the key when the cross appears | 8 minutes | |
Secondary | divided attention TAP Subtest | first task :a cross appears on the screen in which a varying number of crosses appear simultaneously. when four of these crosses form a square, then please press the key as quickly as possible. second task: in this task you will hear a high and a low tone in sequence. you must decide whether the same tone occurs twice in a row. Please press the key as quickly as possible. |
5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |